Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meghan B Ward

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cell|June 13, 2025
The neurological toll of CAR T cell therapyMeghan B Ward, Giedre Krenciute
Pharmacological Reviews|October 7, 2024
Therapeutic advantage of combinatorial CAR T cell and chemo-therapiesMeghan B Ward, Amber B Jones, Giedre Krenciute
Trends in Molecular Medicine|January 16, 2026
Mapping clinical CAR-T cells: insights from scRNA-seqMichaela M Meehl, Meghan B Ward, Giedre Krenciute
Pharmacological Reviews|February 14, 2025
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapiesMeghan B Ward, Amber B Jones, Giedre Krenciute
Nature Chemistry|October 3, 2018
Superoxide dismutase activity enabled by a redox-active ligand rather than metalMeghan B Ward, Andreas Scheitler, Meng Yu, et al.
Inorganic Chemistry|February 14, 2017
Adding a Second Quinol to a Redox-Responsive MRI Contrast Agent Improves Its Relaxivity Response to H<sub>2</sub>O<sub>2</sub>Meng Yu, Meghan B Ward, Alicja Franke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune ResponseSanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cell|June 13, 2025
The neurological toll of CAR T cell therapyMeghan B Ward, Giedre Krenciute
Pharmacological Reviews|October 7, 2024
Therapeutic advantage of combinatorial CAR T cell and chemo-therapiesMeghan B Ward, Amber B Jones, Giedre Krenciute
Trends in Molecular Medicine|January 16, 2026
Mapping clinical CAR-T cells: insights from scRNA-seqMichaela M Meehl, Meghan B Ward, Giedre Krenciute
Pharmacological Reviews|February 14, 2025
Therapeutic advantage of combinatorial chimeric antigen receptor T cell and chemotherapiesMeghan B Ward, Amber B Jones, Giedre Krenciute
Nature Chemistry|October 3, 2018
Superoxide dismutase activity enabled by a redox-active ligand rather than metalMeghan B Ward, Andreas Scheitler, Meng Yu, et al.
Inorganic Chemistry|February 14, 2017
Adding a Second Quinol to a Redox-Responsive MRI Contrast Agent Improves Its Relaxivity Response to H<sub>2</sub>O<sub>2</sub>Meng Yu, Meghan B Ward, Alicja Franke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2025
B7-H3 CAR T Cells Are Effective against Ependymomas but Limited by Tumor Size and Immune ResponseSanya Mehta, Siri Ippagunta, Srinidhi Varadharajan, et al.
Pageof 1